ASOP Global Honors Sens. Feinstein and Portman for Efforts to Protect Patients Online
November 15, 2018
At a Capitol Hill reception today the nonprofit Alliance for Safe Online Pharmacies (ASOP Global) awarded Sen. Dianne Feinstein (D-CA) and Sen. Rob Portman (R-OH) the organization’s annual ASOP Global Patient Safety Champion Award and STOP Act Champion Award, respectively.

Les Canadiens réclament un règlement sur les pharmacies en ligne
November 14, 2018
Une nouvelle étude révèle les perceptions et les comportements des consommateurs canadiens à l’égard des pharmacies en ligne

Canadians Demand Regulation of Online Pharmacies
November 14, 2018
A new consumer study released today by the Alliance for Safe Online Pharmacies (ASOP Global) found that the majority (64%) of Canadian citizens think they should have the option to purchase their prescription medication online.

ASOP Global Statement on Bing/NABP Pilot Program
November 13, 2018
ASOP Global commends Microsoft’s search engine Bing for partnering with the National Association of the Boards of Pharmacy (NABP).

ASOP Global’s Annual Internet Pharmacy Safety Award Presented to .DK Hostmaster 
October 22, 2018
The Alliance for Safe Online Pharmacies (ASOP Global) presented its annual Internet Pharmacy Safety E-Commerce Leadership Award to .DK Hostmaster at the 2018 ICANN63 today.

ASOP EU-EAASM Autumn 2018 Newsletter
September 25, 2018
A diary of achievements from January to September 2018.

G2 Web Services Joins ASOP Global as New Member
August 7, 2018
The Alliance for Safe Online Pharmacies (ASOP Global) announced today that merchant risk management firm G2 Web Services has joined as a new member dedicated to combatting illegal online drug sellers.

ASOP Canada Statement Regarding Unauthorized EpiPen Sales Through Second-Hand Sellers
August 9, 2018
ASOP Canada is expressing concern following recent reports of the EpiPen auto-injector being sold online through second hand vendor sites.

ASOP Global Statement Welcoming Young People in Recovery as New Member
August 7, 2018
ASOP Global welcomes substance abuse recovery nonprofit Young People in Recovery as a new member organization.

ASOP Global Statement Regarding the Announcement of a Drug Importation Working Group at FDA
July 19, 2018
ASOP Global Statement on announcement of new drug importation working group at FDA.

ASOP Global Statement on FDA Warnings to Websites Marketing Unapproved Opioids
June 5, 2018
Statement on warning letters issued by the FDA to online networks that market unapproved opioids to consumers.

ASOP Global Statement on Largest U.S. Multi-Agency Investigation to Disrupt Sales of Illegal and Counterfeit Pharmaceuticals
May 10, 2018
ASOP Global Statement on law enforcement actions against illegal and counterfeit pharmaceuticals sales in California and Arizona.

Statement on ASOP Global Mission, Members and Funding and Drug Importation Position
May 7, 2018
Statement on ASOP Global Mission, Members and Funding and Drug Importation Position

ASOP Canada Statement on Canada Drugs Case
May 2018
ASOP Canada statement on Canada Drugs case.

ASOP Global CanadaDrugs Statement
May 1, 2018
ASOP Global is pleased that CanadaDrugs case has been settled after years of hard work by U.S. government, federal and state law enforcement and prosecutors to get justice for American patients and their families.

ASOP Global Statement on Congressional Hearings with Facebook CEO Mark Zuckerberg
April 12, 2018
ASOP Global statement regarding Facebook hearing testimony

Alliance for Safe Online Pharmacies Launches ASOP Canada to Protect Canadians from Unsafe Medicine
April 5, 2018
The Alliance for Safe Online Pharmacies (ASOP Global) has launched a local chapter in Canada to better protect Canadians from the illegal online sale of medical products

Fake Medicines Continue to Threaten Consumers – EU Member States Have an Obligation to Act
February 21, 2018
ASOP EU Releases a Progress Report on Public Awareness Campaigns by Country.

ASOP Global Commends the USTR for their 2017 Notorious Markets List
January 16, 2018
ASOP Global statement in response to The Office of the United States Trade Representative (USTR) 2017 Notorious Markets List.